InSite Vision

InSite Vision

InSite Vision develops therapeutic products for common eye problems: infection, pain and inflammation in ocular surgery and glaucoma.

Launch date
Employees
Market cap
-
Enterprise valuation
€44m (Public information from Sep 2015)
Alameda California (HQ)
  • Edit
DateInvestorsAmountRound
N/A

$22.2m

Growth Equity VC
N/A

$2.4m

Debt

$48.0m

Valuation: $48.0m

Acquisition
Total Funding€20.2m

Recent News about InSite Vision

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.